Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its
Read More
Pharmaceuticals
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro
Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its
Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for
Read More
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik Tavitian |
Read More
What obesity drugmakers see next in the market: More pills, easier access and drug
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |
Read More
UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround
UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday,
Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec. 19, 2025.
Read More
Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |
Read More
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.Â
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of
Read More
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump’s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way
Read More